NHS National Framework for Ruxolitinib

Published

2 September 2026

Estimated value

£105,900,000

Place of performance

UKC

Lots

1

Notice number

083136-2026

Reference

ocds-h6vhtk-06891c

Official source

Official source

CPV codes

• 33600000Pharmaceutical products

Description

Project title: NHS National Framework for Ruxolitinib Offer reference number: CM/TNS/26/5755 Period of framework: 01 April 2028 to 31 March 2029 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Official publications

• FTS · 083136-2026 · 2 September 2026

Other tenders from NHS England

• Soft Skills Course for GP IMGs (2026-2031) · 30 September 2026
• National Gambling Helpline · 30 September 2026
• Leadership Development to Support Engagement and Learning for Harmed Families · 30 September 2026
• Master’s Level Paediatric Audiology Modules Lot 2 · 30 September 2026
• NHS National Framework for Lenvatinib · 30 September 2026
• Agenda for Change Job Evaluation Digital System · 30 September 2026
• Professional and Generic Skills Programme · 29 September 2026
• Prescription Exemption Checking Service (PECS) 2026/2027 · 29 September 2026
• Dental exemption checking service (Decs) 2026/2027 · 29 September 2026
• PCS National Assurance for Primary Care Contractor 2026-27 · 29 September 2026

See all →

Frequently asked questions

What is the estimated value of this tender?

The estimated value published by the buyer is £105,900,000.

Who is the buyer of this tender?

The contracting authority is NHS England (United Kingdom).

How can I bid for public tenders in the United Kingdom?

Bids are submitted through the official public procurement portal in the United Kingdom. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.